656 related articles for article (PubMed ID: 18690004)
1. Costs and effects of prenatal screening methods for Down syndrome and neural tube defects.
Hoogendoorn M; Evers SM; Schielen PC; van Genugten ML; de Wit GA; Ament AJ
Community Genet; 2008; 11(6):359-67. PubMed ID: 18690004
[TBL] [Abstract][Full Text] [Related]
2. A cost-effectiveness analysis of prenatal screening strategies for Down syndrome.
Odibo AO; Stamilio DM; Nelson DB; Sehdev HM; Macones GA
Obstet Gynecol; 2005 Sep; 106(3):562-8. PubMed ID: 16135588
[TBL] [Abstract][Full Text] [Related]
3. First- and second-trimester evaluation of risk for Down syndrome.
Ball RH; Caughey AB; Malone FD; Nyberg DA; Comstock CH; Saade GR; Berkowitz RL; Gross SJ; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Emig D; D'Alton ME;
Obstet Gynecol; 2007 Jul; 110(1):10-7. PubMed ID: 17601890
[TBL] [Abstract][Full Text] [Related]
4. An outcomes analysis of five prenatal screening strategies for trisomy 21 in women younger than 35 years.
Biggio JR; Morris TC; Owen J; Stringer JS
Am J Obstet Gynecol; 2004 Mar; 190(3):721-9. PubMed ID: 15042005
[TBL] [Abstract][Full Text] [Related]
5. Trends in state/population-based Down syndrome screening and invasive prenatal testing with the introduction of first-trimester combined Down syndrome screening, South Australia, 1995-2005.
Muller PR; Cocciolone R; Haan EA; Wilkinson C; Scott H; Sage L; Bird R; Hutchinson R; Chan A
Am J Obstet Gynecol; 2007 Apr; 196(4):315.e1-7; discussion 285-6. PubMed ID: 17403402
[TBL] [Abstract][Full Text] [Related]
6. Sequential and contingent prenatal screening for Down syndrome.
Wald NJ; Rudnicka AR; Bestwick JP
Prenat Diagn; 2006 Sep; 26(9):769-77. PubMed ID: 16821246
[TBL] [Abstract][Full Text] [Related]
7. [Serum analysis in pregnant women. Mass screening is an effective way to discover chromosome aberrations--arguments for and against].
Kristoffersson U; Nørgaard-Pedersen B
Lakartidningen; 1995 Mar; 92(12):1205-6, 1211-2. PubMed ID: 7535873
[No Abstract] [Full Text] [Related]
8. Down syndrome: prenatal risk assessment and diagnosis.
Newberger DS
Am Fam Physician; 2000 Aug; 62(4):825-32, 837-8. PubMed ID: 10969860
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness model for first-trimester versus second-trimester ultrasound screening for Down syndrome.
Kott B; Dubinsky TJ
J Am Coll Radiol; 2004 Jun; 1(6):415-21. PubMed ID: 17411619
[TBL] [Abstract][Full Text] [Related]
10. [Screening for Down syndrome using first-trimester combined screening followed by second trimester ultrasound examination in an unselected population].
Rozenberg P; Bussières L; Chevret S; Bernard JP; Malagrida L; Cuckle H; Chabry C; Durand-Zaleski I; Bidat L; Lacroix I; Moulis M; Roger M; Jacquemot MC; Bault JP; Boukobza P; Boccara P; Vialat F; Giudicelli Y; Ville Y
Gynecol Obstet Fertil; 2007 Apr; 35(4):303-11. PubMed ID: 17350315
[TBL] [Abstract][Full Text] [Related]
11. [Maternal serum screening for Down syndrome and neural tube defects].
van Rijn M; Christiaens GC; van der Schouw YT; Hagenaars AM; de Pater JM; Visser GH
Ned Tijdschr Geneeskd; 1998 Feb; 142(8):409-15. PubMed ID: 9562776
[TBL] [Abstract][Full Text] [Related]
12. First-trimester combined screening for Down syndrome and other fetal anomalies.
O'Leary P; Breheny N; Dickinson JE; Bower C; Goldblatt J; Hewitt B; Murch A; Stock R
Obstet Gynecol; 2006 Apr; 107(4):869-76. PubMed ID: 16582125
[TBL] [Abstract][Full Text] [Related]
13. A cost-benefit analysis of prenatal detection of Down syndrome and neural tube defects in older mothers.
Sadovnick AD; Baird PA
Am J Med Genet; 1981; 10(4):367-78. PubMed ID: 6460445
[TBL] [Abstract][Full Text] [Related]
14. Prenatal screening for Down syndrome in Australia: costs and benefits of current and novel screening strategies.
O'Leary P; Maxwell S; Murch A; Hendrie D
Aust N Z J Obstet Gynaecol; 2013 Oct; 53(5):425-33. PubMed ID: 24090461
[TBL] [Abstract][Full Text] [Related]
15. First trimester predictors of adverse pregnancy outcomes.
Brameld KJ; Dickinson JE; O'Leary P; Bower C; Goldblatt J; Hewitt B; Murch A; Stock R
Aust N Z J Obstet Gynaecol; 2008 Dec; 48(6):529-35. PubMed ID: 19133038
[TBL] [Abstract][Full Text] [Related]
16. [Prenatal serum screening of aneuploidy and of neural tube defects in the second trimester of pregnancy among the population of Luxembourg. Evaluation of risk by the triple test (AFP+THCG+UE3)].
Thix J
Bull Soc Sci Med Grand Duche Luxemb; 1997; 134(1):25-9. PubMed ID: 9303823
[TBL] [Abstract][Full Text] [Related]
17. Options for Down syndrome screening: what will women choose?
Grant SS
J Midwifery Womens Health; 2005; 50(3):211-8. PubMed ID: 15894999
[TBL] [Abstract][Full Text] [Related]
18. Maternal serum triple analyte screening in pregnancy.
Cate S
Am Fam Physician; 2000 Aug; 62(4):738, 740. PubMed ID: 10969855
[No Abstract] [Full Text] [Related]
19. [Prenatal diagnosis of chromosome aberrations after implementation of screening for Down's syndrome].
Kjaergaard S; Hahnemann JM; Skibsted L; Jensen LN; Sperling L; Zingenberg H; Kristiansen A; Brøndum-Nielsen K
Ugeskr Laeger; 2008 Mar; 170(14):1152-6. PubMed ID: 18405480
[TBL] [Abstract][Full Text] [Related]
20. Is screening for fetal anomalies reliable in HIV-infected pregnant women? A multicentre study.
Brossard P; Boulvain M; Coll O; Barlow P; Aebi-Popp K; Bischof P; Martinez de Tejada B; ;
AIDS; 2008 Oct; 22(15):2013-7. PubMed ID: 18784463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
